Michael Osleber, MD
MOHS-Micrographic Surgery · Little Rock, ARNPI 1003013384
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $685 and has fallen 63.6% since, to $249 in 2025.
Across 152 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$432
- AbbVie$342
- Johnson & Johnson$318
- Regeneron Healthcare Solutions, Inc.$314
- Sun Pharmaceutical Industries Inc.$251
- Sanofi$139
- plus $698 from 14 others
Across 5 payments — averaging $565.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Sitesaver Inc.$3K
What the payments were for
- Food & beverage$2,493100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 34 | $432 |
| AbbVie | 18 | $342 |
| Johnson & Johnson | 39 | $318 |
| Regeneron Healthcare Solutions, Inc. | 8 | $314 |
| Sun Pharmaceutical Industries Inc. | 13 | $251 |
| Sanofi | 6 | $139 |
| Organogenesis Inc. | 3 | $128 |
| LEO Pharma Inc. | 6 | $119 |
| Incyte Corporation | 4 | $85 |
| UCB, Inc. | 3 | $69 |
| Novartis | 3 | $68 |
| Genentech USA, Inc. | 3 | $44 |
| Pfizer | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Organon | 2 | $30 |
| Dermavant Sciences, Inc. | 2 | $27 |
| Biofrontera Inc. | 1 | $21 |
| Journey Medical Corporation | 1 | $16 |
| Convatec Inc. | 1 | $15 |
| Dermira, Inc. | 1 | $13 |
How this compares
Too few mohs-micrographic surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 14 | $809 |
| Ketoconazole | 44 | $803 |
| Triamcinolone Acetonide | 59 | $569 |
| Doxycycline Hyclate | 27 | $288 |
| Mupirocin | 19 | $172 |
| Hydrocortisone | 33 | $136 |
| Cephalexin | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Little Rock
- Scott DinehartLittle Rock$268K
- Justin McLawhornLittle Rock$13K
- Joseph PurnellLittle Rock$1K
- Randall BreauLittle Rock$1K
- Colton NielsonJonesboro$13K
- Kattie AllenBentonville$6K
- Courtney BookBentonville$5K
- Mark NaylorFayetteville$3K
- Stephen MasonHot Springs$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.